Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShort-Term Debt repayments
Ratios

Kiora Pharmaceuticals (KPRX) Accumulated Depreciation & Amortization (2016 - 2025)

Kiora Pharmaceuticals' Accumulated Depreciation & Amortization history spans 10 years, with the latest figure at $24801.0 for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization rose 29.14% year-over-year to $24801.0; the TTM value through Dec 2025 reached $24801.0, up 29.14%, while the annual FY2025 figure was $24801.0, 29.14% up from the prior year.
  • Accumulated Depreciation & Amortization reached $24801.0 in Q4 2025 per KPRX's latest filing, up from $19205.0 in the prior quarter.
  • In the past five years, Accumulated Depreciation & Amortization ranged from a high of $108378.0 in Q3 2021 to a low of $19205.0 in Q4 2024.
  • Average Accumulated Depreciation & Amortization over 4 years is $64334.6, with a median of $51798.0 recorded in 2023.
  • Peak YoY movement for Accumulated Depreciation & Amortization: tumbled 62.92% in 2024, then increased 29.14% in 2025.
  • A 4-year view of Accumulated Depreciation & Amortization shows it stood at $45296.0 in 2021, then grew by 14.35% to $51798.0 in 2023, then crashed by 62.92% to $19205.0 in 2024, then increased by 29.14% to $24801.0 in 2025.
  • Per Business Quant, the three most recent readings for KPRX's Accumulated Depreciation & Amortization are $24801.0 (Q4 2025), $19205.0 (Q4 2024), and $51798.0 (Q4 2023).